Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Millions eat, heal, study, and cheer in venues run by Aramark. That reach translates into dense disclosures on food-cost inflation, long-term campus contracts, and the recent uniform-business spin-off. If you have ever searched for “Aramark insider trading Form 4 transactions� or wondered how a stadium caterer books revenue, you know the challenge: hundreds of pages, multiple exhibits, shifting segment names.
Stock Titan turns that sprawl into clarity. Our AI parses every 10-K and 10-Q the moment it hits EDGAR, flags labor-expense swings, and delivers a plain-English summary so “Aramark quarterly earnings report 10-Q filing� becomes a five-minute read. Need fast context on a surprise press release? We attach an “Aramark 8-K material events explained� card next to the source PDF. AG˹ٷ-time alerts surface “Aramark Form 4 insider transactions� so you can see when executives adjust holdings before new contract wins. Even the proxy—searchable under “Aramark proxy statement executive compensation”—is distilled to show incentive targets tied to food-service margins.
Everything is in one feed, updated instantly: annual report 10-K simplified, earnings report filing analysis, executive stock transactions Form 4, shelf registrations, and governance charters. Use it to compare segment performance across campuses and healthcare, monitor commodity-price hedges, or simply save hours understanding Aramark SEC documents with AI. Complex operations, explained simply—so you can focus on decisions, not document hunts.
Prospect Capital Corporation (PSEC) has filed a preliminary pricing supplement for three new unsecured senior notes under its InterNotes® program:
- 7.500% Notes due 2028 � CUSIP 74348GWC0
- 7.750% Notes due 2030 � CUSIP 74348GWD8
- 8.000% Notes due 2032 � CUSIP 74348GWE6
All issues are offered in $1,000 denominations, pay semi-annual interest beginning 15 Jan 2026 and are callable at par on or after 15 Jan 2026. A Survivor’s Option allows early repayment upon the holder’s death, subject to annual caps.
Pricing details (pre-fee): 2028 Notes sold at 101.125%, 2030 at 101.700% and 2032 at 101.950%, implying modest premiums to face value. Gross concessions range from 1.125% to 1.950%.
Strategic context
- Liability management: In Apr-Jun 2025 PSEC fully retired its $342.9 m 3.706% Notes due 2026 via tender (99% plus accrued) and subsequent redemption, eliminating a nearer-term maturity.
- Portfolio re-positioning: Sold subordinated structured notes with $324.6 m cost basis for $74.6 m cash; provided $39.6 m of new first-lien financing to National Property REIT Corp., received $19 m of repayments, and closed the acquisition of QC Holdings with a $55 m senior loan plus $22.3 m equity.
Capital structure impact
- New notes will rank pari passu with existing unsecured debt and be structurally subordinated to $0.7 bn of secured borrowings (Feb 2023) under the credit facility.
- Coupons of 7.5-8.0% exceed the retired 3.706% issue, indicating materially higher future interest expense but extend the weighted-average maturity to 2028-2032.
Key dates: Trade 14 Jul 2025, settle 17 Jul 2025; interest accrues from settlement.
Risks highlighted include rising leverage, higher funding costs, covenant limitations under the revolver, potential rating pressure, and market volatility in SOFR-linked issuances. No earnings metrics were provided in this filing.
STMicroelectronics (STM) has released a Form 6-K reporting routine activity under its 2024 share-buyback program. During the week of 30&Բ;ܲԱ&Բ;�&Բ;4&Բ;ܱ&Բ;2025, the company repurchased 202,801 ordinary shares (�0.02% of issued capital) on Euronext Paris at a weighted-average price of �26.0578, for a total outlay of �5.28&Բ;Dz. Following these purchases, STM now holds 16,724,034 treasury shares, representing about 1.8% of total shares outstanding. The repurchases are executed to satisfy employee equity plans and may be re-allocated for other lawful purposes under EU Market Abuse Regulation article 5(2). No changes to guidance, capital structure strategy, or operational outlook were disclosed.